By Agencies The results of a small trial of an experimental Ebola vaccine in humans shows that it appears safe, produces an immune response and is well tolerated, prompting support for its development to be fast-tracked. The candidate vaccine is being jointly developed by the National Institute of Allergy and …
Read More »